Novavax to Deliver 60 Million Doses of COVID-19 Vaccine Candidate to UK for Trial

U.S. drug developer Novavax Inc said on Friday the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373, for a phase 3 clinical trial in the country. The company and the UK ...